Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
about
MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study.Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease.Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets.Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung CancerCirculating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study.MUC1 overexpression predicts worse survival in patients with non-small cell lung cancer: evidence from an updated meta-analysis.Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer.Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.
P2860
Q33555885-3102BA25-CE1E-4F1D-9A14-86784DB471D1Q35179046-2E59B7BD-7724-4070-B427-8CE2AD23DBAFQ39034922-2F6EA85D-0E2A-40F3-A101-6172431D861AQ39535574-04388A7E-32E1-43D4-88AA-168CA391D56BQ41460801-013F17F8-1082-4CE2-9F9D-22FBD251A7AEQ41461528-AE72899B-6A4E-4C4C-AB38-A690C63D8356Q41892187-598FB40D-1B4F-4B98-8FDF-C7EA98E7618AQ47139445-AF435A0C-FD16-4691-9291-5B9F7D905CA9Q51554706-C8E4C00A-274D-4421-B5A2-7CE5DDAA85A6Q51576825-3C652CE5-8A91-4E9D-B9FE-40EDAB1D3C9EQ53309734-0C7F4966-7788-48E1-836A-9CFE8B44F53E
P2860
Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Krebs von den Lungen-6 (KL-6) ...... ted nonsmall cell lung cancer.
@ast
Krebs von den Lungen-6 (KL-6) ...... ted nonsmall cell lung cancer.
@en
Krebs von den Lungen-6
@nl
type
label
Krebs von den Lungen-6 (KL-6) ...... ted nonsmall cell lung cancer.
@ast
Krebs von den Lungen-6 (KL-6) ...... ted nonsmall cell lung cancer.
@en
Krebs von den Lungen-6
@nl
prefLabel
Krebs von den Lungen-6 (KL-6) ...... ted nonsmall cell lung cancer.
@ast
Krebs von den Lungen-6 (KL-6) ...... ted nonsmall cell lung cancer.
@en
Krebs von den Lungen-6
@nl
P2093
P2860
P356
P1476
Krebs von den Lungen-6 (KL-6) ...... ted nonsmall cell lung cancer.
@en
P2093
Akihito Yokoyama
Atsushi Takano
Hironobu Hamada
Hiroyasu Shoda
Koji Arihiro
Kouki Inai
Morihito Okada
Noboru Hattori
Nobuhisa Ishikawa
Nobuoki Kohno
P2860
P304
P356
10.1002/IJC.26007
P577
2011-04-27T00:00:00Z